CureVac N.V. (NASDAQ:CVAC) Stock is trading Above 4.23% From 50-Day SMA
Leerink Partners lowered the price target for the CureVac N.V. (NASDAQ:CVAC) stock from “an Outperform” to “a Market perform”. The rating was released on April 25, 2024, according to finviz. The research report from UBS has upgraded the stock from Neutral to Buy, with a price target set at $18. The stock was upgraded by […]
Does CureVac N.V. (CVAC) Stock Really Excited You?
Leerink Partners lowered the price target for the CureVac N.V. (NASDAQ:CVAC) stock from “an Outperform” to “a Market perform”. The rating was released on April 25, 2024, according to finviz. The research report from UBS has upgraded the stock from Neutral to Buy, with a price target set at $18. The stock was upgraded by […]
CureVac N.V. (CVAC) Stock is poised for a successful quarter
Leerink Partners lowered the price target for the CureVac N.V. (NASDAQ:CVAC) stock from “an Outperform” to “a Market perform”. The rating was released on April 25, 2024, according to finviz. The research report from UBS has upgraded the stock from Neutral to Buy, with a price target set at $18. The stock was upgraded by […]
Is CureVac N.V. (CVAC) Stock a good value investment?
SVB Securities raised the price target for the CureVac N.V. (NASDAQ:CVAC) stock to “an Outperform”. The rating was released on June 08, 2023, according to finviz. We previously noted in another research note published on January 19, 2023 by UBS that upgraded the stock from a Neutral to a Buy with a price target of […]
CureVac N.V. (CVAC) Stock creates opportunities due to its volume and complexity
SVB Securities raised the price target for the CureVac N.V. (NASDAQ:CVAC) stock to “an Outperform”. The rating was released on June 08, 2023, according to finviz. We previously noted in another research note published on January 19, 2023 by UBS that upgraded the stock from a Neutral to a Buy with a price target of […]
Trading CureVac N.V. (CVAC) Stock is a good strategy
SVB Securities raised the price target for the CureVac N.V. (NASDAQ:CVAC) stock to “an Outperform”. The rating was released on June 08, 2023, according to finviz. We previously noted in another research note published on January 19, 2023 by UBS that upgraded the stock from a Neutral to a Buy with a price target of […]
